Lee Sweeney
#74,041
Most Influential Person Now
American scientist
Lee Sweeney's AcademicInfluence.com Rankings
Lee Sweeneybiology Degrees
Biology
#5195
World Rank
#7621
Historical Rank
#1836
USA Rank
Cell Biology
#202
World Rank
#209
Historical Rank
#50
USA Rank
Molecular Biology
#644
World Rank
#659
Historical Rank
#164
USA Rank
Genetics
#580
World Rank
#660
Historical Rank
#215
USA Rank
Download Badge
Biology
Lee Sweeney's Degrees
- PhD Biology Stanford University
- Masters Biochemistry Stanford University
- Bachelors Chemistry Stanford University
Why Is Lee Sweeney Influential?
(Suggest an Edit or Addition)According to Wikipedia, H. Lee Sweeney is an American scientist who studies muscle. Education and career He received his undergraduate degree in biochemistry from Massachusetts Institute of Technology in 1975 and his PhD from Harvard in physiology and biophysics in 1984. He then spent a year as research instructor in physiology at the University of Texas Southwestern Medical School, and then obtained an appointment as an assistant professor at the University of Texas at Austin.
Lee Sweeney's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Matrix Elasticity Directs Stem Cell Lineage Specification (2006) (11729)
- Myotubes differentiate optimally on substrates with tissue-like stiffness (2004) (1629)
- Dystrophin protects the sarcolemma from stresses developed during muscle contraction. (1993) (1410)
- Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle (2001) (1118)
- PTC124 targets genetic disorders caused by nonsense mutations (2007) (1057)
- The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy (1991) (889)
- Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. (1998) (715)
- Myosin VI is an actin-based motor that moves backwards (1999) (666)
- Myosin light chain phosphorylation in vertebrate striated muscle: regulation and function. (1993) (637)
- Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. (1999) (570)
- Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice (2002) (475)
- A simple analysis of the "phosphocreatine shuttle". (1984) (468)
- The kinetic mechanism of myosin V. (1999) (414)
- Myosin VI is a processive motor with a large step size (2001) (384)
- Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance (2006) (379)
- Ataluren treatment of patients with nonsense mutation dystrophinopathy (2014) (373)
- Structural and functional insights into the Myosin motor mechanism. (2010) (350)
- A 35-Å movement of smooth muscle myosin on ADP release (1995) (341)
- Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy (2008) (333)
- Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. (1999) (313)
- Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (2017) (302)
- Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. (2007) (298)
- A structural state of the myosin V motor without bound nucleotide (2003) (292)
- Three myosin V structures delineate essential features of chemo‐mechanical transduction (2004) (281)
- Alteration of cross-bridge kinetics by myosin light chain phosphorylation in rabbit skeletal muscle: implications for regulation of actin-myosin interaction. (1990) (267)
- The Mechanism of Myosin VI Translocation and Its Load-Induced Anchoring (2004) (252)
- Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. (1998) (252)
- Adeno-associated virus (AAV) serotype 9 provides global cardiac gene transfer superior to AAV1, AAV6, AAV7, and AAV8 in the mouse and rat. (2008) (251)
- Myosin alkali light chain and heavy chain variations correlate with altered shortening velocity of isolated skeletal muscle fibers. (1988) (242)
- Kinetic Tuning of Myosin via a Flexible Loop Adjacent to the Nucleotide Binding Pocket* (1998) (240)
- Kinetic Mechanism and Regulation of Myosin VI* (2001) (228)
- Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy (2015) (219)
- The structure of the myosin VI motor reveals the mechanism of directionality reversal (2005) (210)
- Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (2013) (208)
- Myosin light chain phosphorylation affects the structure of rabbit skeletal muscle thick filaments. (1996) (204)
- Supplemental Data Matrix Elasticity Directs Stem Cell Lineage Specification (2006) (201)
- Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. (2000) (199)
- Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. (1994) (195)
- Rescue of Dystrophic Skeletal Muscle by PGC-1α Involves a Fast to Slow Fiber Type Shift in the mdx Mouse (2012) (193)
- Extracellular matrix elasticity directs stem cell differentiation. (2007) (189)
- Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. (2004) (188)
- Abnormal contractile properties of muscle fibers expressing beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. (1995) (178)
- A force-dependent state controls the coordination of processive myosin V. (2005) (176)
- Adaptations in myosin heavy chain expression and contractile function in dystrophic mouse diaphragm. (1993) (168)
- A Model of Myosin V Processivity* (2004) (165)
- In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. (1996) (159)
- Functional analyses of troponin T mutations that cause hypertrophic cardiomyopathy: insights into disease pathogenesis and troponin function. (1998) (159)
- Role of the lever arm in the processive stepping of myosin V (2002) (158)
- Site-directed mutation of the trigger calcium-binding sites in cardiac troponin C. (1989) (157)
- Myosin VI Steps via a Hand-over-Hand Mechanism with Its Lever Arm Undergoing Fluctuations when Attached to Actin* (2004) (157)
- Myosin motors: missing structures and hidden springs. (2001) (156)
- Phosphorylation of myosin in permeabilized mammalian cardiac and skeletal muscle cells. (1986) (155)
- Altered Smooth Muscle Cell Force Generation as a Driver of Thoracic Aortic Aneurysms and Dissections. (2017) (152)
- The structure of the rigor complex and its implications for the power stroke. (2004) (143)
- Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies. (2001) (139)
- Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action. (1996) (137)
- Spare the rod, spoil the regulation: necessity for a myosin rod. (1997) (135)
- ADP inhibition of myosin V ATPase activity. (2000) (129)
- Muscle degeneration without mechanical injury in sarcoglycan deficiency. (1999) (128)
- Independent assembly of 1.6 microns long bipolar MHC filaments and I-Z-I bodies. (1997) (125)
- Charge replacement near the phosphorylatable serine of the myosin regulatory light chain mimics aspects of phosphorylation. (1994) (124)
- Myosin VI Rewrites the Rules for Myosin Motors (2010) (124)
- Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort (2016) (123)
- Myostatin activation in patients with advanced heart failure and after mechanical unloading (2010) (121)
- How Myosin Generates Force on Actin Filaments. (2016) (120)
- Full-length myosin VI dimerizes and moves processively along actin filaments upon monomer clustering. (2006) (120)
- Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: Effects of age and disease progression (2014) (118)
- Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS (2014) (118)
- 31P NMR spectroscopy, chemical analysis, and free Mg2+ of rabbit bladder and uterine smooth muscle. (1986) (117)
- Gene Transfer of Hepatocyte Growth Factor Attenuates Postinfarction Heart Failure (2003) (116)
- Myosin IIB Is Unconventionally Conventional* (2003) (115)
- T2 mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross‐sectional study of lower leg muscles in 5–15‐year‐old boys with Duchenne muscular dystrophy (2013) (113)
- Adhesion-contractile balance in myocyte differentiation (2004) (109)
- Cargo binding induces dimerization of myosin VI (2009) (106)
- Viral Gene Transfer of the Antiapoptotic Factor Bcl-2 Protects Against Chronic Postischemic Heart Failure (2002) (106)
- What can myosin VI do in cells? (2007) (101)
- Changes in fiber composition of soleus muscle during rat hindlimb suspension. (1988) (101)
- A flexible domain is essential for the large step size and processivity of myosin VI. (2005) (99)
- Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer. (2000) (98)
- How actin initiates the motor activity of Myosin. (2015) (92)
- Osteopontin ablation ameliorates muscular dystrophy by shifting macrophages to a pro-regenerative phenotype (2016) (92)
- Myosin VI dimerization triggers an unfolding of a three-helix bundle in order to extend its reach. (2009) (92)
- PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy (2014) (92)
- Supraphysiological levels of GDF11 induce striated muscle atrophy (2017) (92)
- Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy (2012) (90)
- Chemical shift‐based MRI to measure fat fractions in dystrophic skeletal muscle (2014) (89)
- Actin and light chain isoform dependence of myosin V kinetics. (2000) (84)
- A Myo6 Mutation Destroys Coordination between the Myosin Heads, Revealing New Functions of Myosin VI in the Stereocilia of Mammalian Inner Ear Hair Cells (2008) (84)
- A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2C. (2012) (83)
- Kinetic mechanism of blebbistatin inhibition of nonmuscle myosin IIb. (2004) (83)
- Long-term restoration of cardiac dystrophin expression in golden retriever muscular dystrophy following rAAV6-mediated exon skipping. (2012) (83)
- Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. (2013) (82)
- Induction of Angiogenesis and Inhibition of Apoptosis by Hepatocyte Growth Factor Effectively Treats Postischemic Heart Failure (2005) (81)
- Structural and functional responses of mammalian thick filaments to alterations in myosin regulatory light chains. (1998) (79)
- Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study (2014) (79)
- Velocity of shortening and myosin isozymes in two types of rabbit fast-twitch muscle fibers. (1986) (78)
- Rare, Nonsynonymous Variant in the Smooth Muscle-Specific Isoform of Myosin Heavy Chain, MYH11, R247C, Alters Force Generation in the Aorta and Phenotype of Smooth Muscle Cells (2012) (78)
- Unregulated smooth-muscle myosin in human intestinal neoplasia (2008) (77)
- Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction. (1998) (77)
- Muscle : fundamental biology and mechanisms of disease (2012) (77)
- Noninvasive measurement of gene expression in skeletal muscle. (2000) (76)
- Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. (2010) (75)
- The unique insert in myosin VI is a structural calcium-calmodulin binding site. (2004) (75)
- Force-producing ADP state of myosin bound to actin (2016) (74)
- Kinetic characterization of the weak binding states of myosin V. (2002) (74)
- Magnesium Regulates ADP Dissociation from Myosin V* (2005) (73)
- The Structural Basis for the Large Powerstroke of Myosin VI (2007) (73)
- Functional role of loop 2 in myosin V. (2004) (72)
- Quantitative electrophoretic analysis of myosin heavy chains in single muscle fibers. (2001) (71)
- The unique insert at the end of the myosin VI motor is the sole determinant of directionality (2007) (70)
- Activin IIB receptor blockade attenuates dystrophic pathology in a mouse model of duchenne muscular dystrophy (2010) (70)
- Changes in interfilament spacing mimic the effects of myosin regulatory light chain phosphorylation in rabbit psoas fibers. (1998) (70)
- Two Conserved Lysines at the 50/20-kDa Junction of Myosin Are Necessary for Triggering Actin Activation* (2001) (69)
- Motor Proteins. (2018) (68)
- The motor mechanism of myosin V: insights for muscle contraction. (2004) (67)
- Function of the N terminus of the myosin essential light chain of vertebrate striated muscle. (1995) (67)
- Muscle Contraction. (2018) (66)
- Urinary creatinine excretion, bioelectrical impedance analysis, and clinical outcomes in patients with CKD: the CRIC study. (2014) (66)
- Thymosin-β4 Changes the Conformation and Dynamics of Actin Monomers (2000) (65)
- How myosin VI coordinates its heads during processive movement (2007) (64)
- Noninvasive monitoring of stem cell transfer for muscle disorders (2004) (62)
- Systemic Myostatin Inhibition via Liver-Targeted Gene Transfer in Normal and Dystrophic Mice (2010) (62)
- Correction of the dystrophic phenotype by in vivo targeting of muscle progenitor cells. (2003) (61)
- Myosin Va and myosin VI coordinate their steps while engaged in an in vitro tug of war during cargo transport (2011) (59)
- Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines. (2008) (59)
- Chronic Losartan Administration Reduces Mortality and Preserves Cardiac but Not Skeletal Muscle Function in Dystrophic Mice (2011) (59)
- The myosin X motor is optimized for movement on actin bundles (2016) (59)
- Kinetic and Spectroscopic Evidence for Three Actomyosin:ADP States in Smooth Muscle* (2000) (58)
- Noninvasive monitoring of gene correction in dystrophic muscle (2005) (58)
- Force Generation by Myosin Motors: A Structural Perspective. (2020) (58)
- Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy. (2005) (57)
- Attenuation of skeletal muscle atrophy via protease inhibition. (2005) (56)
- Overexpression of SERCA1a in the mdx diaphragm reduces susceptibility to contraction-induced damage. (2010) (55)
- Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling. (2004) (55)
- Overexpression of insulin‐like growth factor‐1 attenuates skeletal muscle damage and accelerates muscle regeneration and functional recovery after disuse (2013) (54)
- A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy (2017) (54)
- Blocking free radical production via adenoviral gene transfer decreases cardiac ischemia-reperfusion injury. (2000) (54)
- Mutation of the high affinity calcium binding sites in cardiac troponin C. (1992) (54)
- Influence of electrical stimulation on a fast-twitch muscle in aging rats. (1991) (54)
- Initiation and maturation of I-Z-I bodies in the growth tips of transfected myotubes. (1999) (54)
- Long-term systemic myostatin inhibition via liver-targeted gene transfer in golden retriever muscular dystrophy. (2011) (53)
- Molecular extensibility of mini-dystrophins and a dystrophin rod construct. (2005) (53)
- Patterning, prestress, and peeling dynamics of myocytes. (2004) (51)
- Calcium Functionally Uncouples the Heads of Myosin VI* (2003) (51)
- Increased collagen cross‐linking is a signature of dystrophin‐deficient muscle (2016) (51)
- Mutation of smooth muscle myosin causes epithelial invasion and cystic expansion of the zebrafish intestine. (2005) (50)
- Measurements on permeabilized skeletal muscle fibers during continuous activation. (1987) (50)
- DMD genotype correlations from the Duchenne Registry: Endogenous exon skipping is a factor in prolonged ambulation for individuals with a defined mutation subtype (2018) (50)
- Interhead distance measurements in myosin VI via SHRImP support a simplified hand-over-hand model. (2005) (50)
- Transendocardial delivery of AAV6 results in highly efficient and global cardiac gene transfer in rhesus macaques. (2011) (49)
- Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy (2018) (49)
- Inhibition of Matrix Metalloproteinase Activity by TIMP-1 Gene Transfer Effectively Treats Ischemic Cardiomyopathy (2004) (48)
- Long-term administration of the TNF blocking drug Remicade (cV1q) to mdx mice reduces skeletal and cardiac muscle fibrosis, but negatively impacts cardiac function (2014) (47)
- Changes in inorganic phosphate and force production in human skeletal muscle after cast immobilization. (2005) (46)
- Cardiac gene transfer of short hairpin RNA directed against phospholamban effectively knocks down gene expression but causes cellular toxicity in canines. (2011) (46)
- Impact of viral-mediated IGF-I gene transfer on skeletal muscle following cast immobilization. (2010) (46)
- Muscle cell peeling from micropatterned collagen: direct probing of focal and molecular properties of matrix adhesion. (1999) (46)
- Blocking the development of postischemic cardiomyopathy with viral gene transfer of the apoptosis repressor with caspase recruitment domain. (2003) (45)
- Membrane blebbing as an assessment of functional rescue of dysferlin-deficient human myotubes via nonsense suppression. (2010) (45)
- Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy. (2015) (44)
- The importance of the creatine kinase reaction: the concept of metabolic capacitance. (1994) (44)
- The low-affinity Ca2(+)-binding sites in cardiac/slow skeletal muscle troponin C perform distinct functions: site I alone cannot trigger contraction. (1990) (43)
- Nonsense suppression activity of PTC124 (ataluren) (2009) (43)
- Mutational analysis of motor proteins. (1996) (42)
- MR biomarkers predict clinical function in Duchenne muscular dystrophy (2020) (42)
- Disease-modifying effects of orally bioavailable NF-κB inhibitors in dystrophin-deficient muscle. (2016) (42)
- Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy. (2015) (40)
- Magnetic Resonance Assessment of Hypertrophic and Pseudo-Hypertrophic Changes in Lower Leg Muscles of Boys with Duchenne Muscular Dystrophy and Their Relationship to Functional Measurements (2015) (39)
- Assessment of intramuscular lipid and metabolites of the lower leg using magnetic resonance spectroscopy in boys with Duchenne muscular dystrophy (2014) (39)
- Myosin phosphorylation in permeabilized rabbit psoas fibers. (1985) (39)
- Genetic Disruption of Calcineurin Improves Skeletal Muscle Pathology and Cardiac Disease in a Mouse Model of Limb-Girdle Muscular Dystrophy* (2007) (39)
- Neovasculogenic therapy to augment perfusion and preserve viability in ischemic cardiomyopathy. (2006) (38)
- Two single-headed myosin V motors bound to a tetrameric adapter protein form a processive complex (2011) (38)
- Long-term wheel running compromises diaphragm function but improves cardiac and plantarflexor function in the mdx mouse. (2013) (37)
- Preparation of collagen-coated gels that maximize in vitro myogenesis of stem cells by matching the lateral elasticity of in vivo muscle. (2010) (37)
- The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy (2020) (37)
- Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history (2018) (36)
- Efficient transmural cardiac gene transfer by intrapericardial injection in neonatal mice. (1998) (36)
- Myostatin Is Upregulated Following Stress in an Erk-Dependent Manner and Negatively Regulates Cardiomyocyte Growth in Culture and in a Mouse Model (2010) (36)
- Addition of lysines to the 50/20 kDa junction of myosin strengthens weak binding to actin without affecting the maximum ATPase activity. (2003) (36)
- Leupeptin-based inhibitors do not improve the mdx phenotype. (2010) (35)
- An actin-dependent conformational change in myosin (2003) (35)
- Cardiac myosin light chain is phosphorylated by Ca2+/calmodulin-dependent and -independent kinase activities (2016) (35)
- Restoration of Phosphorylation-dependent Regulation to the Skeletal Muscle Myosin Regulatory Light Chain (*) (1995) (34)
- Myosin VI undergoes a 180° power stroke implying an uncoupling of the front lever arm (2009) (33)
- Truncated desmin in PtK2 cells induces desmin-vimentin-cytokeratin coprecipitation, involution of intermediate filament networks, and nuclear fragmentation: a model for many degenerative diseases. (1994) (33)
- Function of the N-terminal calcium-binding sites in cardiac/slow troponin C assessed in fast skeletal muscle fibers. (1991) (33)
- The ADP release step of the smooth muscle cross-bridge cycle is not directly associated with force generation. (1999) (33)
- Phase 1 Study of Edasalonexent (CAT-1004), an Oral NF-κB Inhibitor, in Pediatric Patients with Duchenne Muscular Dystrophy (2018) (32)
- Dispensability of the actin-binding site and spectrin repeats for targeting sarcomeric alpha-actinin into maturing Z bands in vivo: implications for in vitro binding studies. (1998) (32)
- Modeling disease trajectory in Duchenne muscular dystrophy (2020) (31)
- Enhancing the utility of adeno-associated virus gene transfer through inducible tissue-specific expression. (2013) (31)
- Bowman-Birk inhibitor attenuates dystrophic pathology in mdx mice. (2010) (30)
- Tadalafil Treatment Delays the Onset of Cardiomyopathy in Dystrophin‐Deficient Hearts (2016) (30)
- One year transgene expression with adeno-associated virus cardiac gene transfer. (2005) (29)
- Upregulation of paxillin and focal adhesion signaling follows Dystroglycan Complex deletions and promotes a hypertensive state of differentiation. (2011) (28)
- Myosin phosphorylation in smooth and skeletal muscles: regulation and function. (1990) (28)
- The post‐rigor structure of myosin VI and implications for the recovery stroke (2008) (28)
- MRI/MRS evaluation of a female carrier of Duchenne muscular dystrophy (2012) (28)
- IGF-I and vitamin C promote myogenic differentiation of mouse and human skeletal muscle cells at low temperatures. (2011) (27)
- Aging does not affect contractile properties of type IIb FDL muscle in Fischer 344 rats. (1990) (27)
- Structural and Kinetic Studies of Phosphorylation-dependent Regulation in Smooth Muscle Myosin* (1998) (27)
- Myosin regulatory light chain phosphorylation and the production of functionally significant changes in myosin head arrangement on striated muscle thick filaments. (1995) (26)
- γ-Sarcoglycan deficiency increases cell contractility, apoptosis and MAPK pathway activation but does not affect adhesion (2005) (26)
- Thymosin-beta(4) changes the conformation and dynamics of actin monomers. (2000) (25)
- The dystrophin-associated glycoprotein complex: what parts can you do without? (2000) (23)
- Constitutive phosphorylation of myosin phosphatase targeting subunit‐1 in smooth muscle (2014) (23)
- Effects of exercise on cardiac myosin isozyme composition during the aging process. (1988) (23)
- Activin Receptor Type IIB Inhibition Improves Muscle Phenotype and Function in a Mouse Model of Spinal Muscular Atrophy (2016) (23)
- Gene Transfer in Skeletal and Cardiac Muscle Using Recombinant Adeno‐Associated Virus (2013) (23)
- Activin Type II Receptor Ligand Signaling Inhibition After Experimental Ischemic Heart Failure Attenuates Cardiac Remodeling and Prevents Fibrosis. (2019) (22)
- Regulation of Asymmetric Smooth Muscle Myosin II Molecules* (2000) (22)
- How myosin motors power cellular functions – an exciting journey from structure to function (2012) (21)
- Percutaneous Transendocardial Delivery of Self-complementary Adeno-associated Virus 6 Achieves Global Cardiac Gene Transfer in Canines. (2008) (21)
- Myosin VI must dimerize and deploy its unusual lever arm in order to perform its cellular roles. (2014) (21)
- Myosin VI deafness mutation prevents the initiation of processive runs on actin (2015) (20)
- Regulation and tuning of smooth muscle myosin. (1998) (20)
- Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort. (2020) (20)
- Exon‐skipped dystrophins for treatment of Duchenne muscular dystrophy: Mass spectrometry mapping of most exons and cooperative domain designs based on single molecule mechanics (2010) (18)
- Adeno-associated virus vector delivery to the heart. (2011) (18)
- Processive steps in the reverse direction require uncoupling of the lead head lever arm of myosin VI. (2012) (18)
- AAV9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and Rat (2008) (18)
- Distinct Families of Z-Line Targeting Modules in the Cooh-Terminal Region of Nebulin (2000) (18)
- Gene therapy in large animal models of human cardiovascular genetic disease. (2009) (18)
- Myosin VI has a One Track Mind Versus Myosin Va When Moving on Actin Bundles or at an Intersection (2013) (18)
- Myostatin Is Elevated in Congenital Heart Disease and After Mechanical Unloading (2011) (17)
- Role of Insert-1 of Myosin VI in Modulating Nucleotide Affinity* (2011) (17)
- Diastolic Dysfunction and Altered Energetics in the a MHC 403 / 1 Mouse Model of Familial Hypertrophic Cardiomyopathy (1998) (17)
- Fructose 1,6-diphosphate administration attenuates post-ischemic ventricular dysfunction. (2006) (17)
- Glucocorticoids counteract hypertrophic effects of myostatin inhibition in dystrophic muscle. (2019) (17)
- Electrospray ionization mass spectrometry studies of noncovalent myosin VI complexes reveal a new specific calmodulin binding site (2005) (16)
- A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice (2012) (16)
- Correction: Magnetic Resonance Imaging and Spectroscopy Assessment of Lower Extremity Skeletal Muscles in Boys with Duchenne Muscular Dystrophy: A Multicenter Cross Sectional Study (2014) (16)
- The Light Chain-binding Domain of the Smooth Muscle Myosin Heavy Chain Is Not the Only Determinant of Regulation* (1998) (15)
- Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery. (2018) (14)
- Does the S2 rod of myosin II uncoil upon two-headed binding to actin? A leucine-zippered HMM study. (2003) (14)
- The azimuthal path of myosin V and its dependence on lever-arm length (2012) (14)
- High-resolution structures of the actomyosin-V complex in three nucleotide states provide insights into the force generation mechanism (2021) (13)
- Unanticipated temporal and spatial effects of sarcomeric alpha-actinin peptides expressed in PtK2 cells. (1997) (12)
- An intermediate along the recovery stroke of myosin VI revealed by X-ray crystallography and molecular dynamics (2018) (12)
- Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trial (2021) (12)
- 226th ENMC International Workshop: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20–22 January 2017, Heemskerk, The Netherlands (2018) (11)
- Assessment of rAAVrh.74.MHCK7.micro-dystrophin Gene Therapy Using Magnetic Resonance Imaging in Children With Duchenne Muscular Dystrophy (2021) (11)
- 226th ENMC International Workshop: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20–22 January 2017, Heemskerk, The Netherlands (2018) (11)
- Creatine depletion elicits structural, biochemical, and physiological adaptations in rat costal diaphragm. (1996) (10)
- Myosin Structures. (2020) (10)
- Metabolic capacity and myosin expression in single muscle fibres of the garter snake. (1991) (9)
- A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial (2021) (9)
- Graded effects of unregulated smooth muscle myosin on intestinal architecture, intestinal motility and vascular function in zebrafish (2016) (9)
- Functional analyses of cardiomyopathic cardiac troponin T mutants in myocyte culture (1997) (9)
- Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 in the canine. (2011) (9)
- Structure-function analysis of cytoskeletal/contractile proteins in avian myotubes. (1997) (8)
- Erratum: Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats (Journal Applied Physiology (March 2004) 96 (1097-1104)) (2004) (8)
- Sarcomeric-alpha-actinin defective in vinculin-binding causes Z-line expansion and nemaline-like body formation in cultured chick myotubes. (2009) (8)
- Methods in muscle biology (1997) (8)
- Two-Year Longitudinal Changes in Lower Limb Strength and Its Relation to Loss in Function in a Large Cohort of Patients With Duchenne Muscular Dystrophy (2018) (7)
- G.P.3.05 Phase 2 study of PTC124 for nonsense mutation suppression therapy of Duchenne muscular dystrophy (DMD) (2007) (7)
- Status of therapeutic gene transfer to treat canine dilated cardiomyopathy in dogs. (2010) (5)
- Early loss of ambulation is not a representative clinical feature in Duchenne muscular dystrophy dogs: remarks on the article of Barthélémy et al. (2015) (5)
- Independent Assembly of 1 . 6 / an Long Bipolar MHCFilaments and IZI Bodies (2007) (5)
- Gene transfer of arginine kinase to skeletal muscle using adeno-associated virus (2014) (5)
- The Contractile Machinery of Skeletal Muscle (2012) (5)
- Filopodia powered by class x myosin promote fusion of mammalian myoblasts (2021) (5)
- Current state of cardiac troponin testing in Duchenne muscular dystrophy cardiomyopathy: review and recommendations from the Parent Project Muscular Dystrophy expert panel (2021) (4)
- Smooth muscle atrophy and colon pathology in SMN deficient mice. (2019) (4)
- Special Topic: Molecular Motors of Eukaryotic Cells (1996) (4)
- P.13.5 Magnetic resonance imaging and spectroscopy detect changes with age, corticosteroid treatment, and functional progression in DMD (2013) (4)
- Duchenne Regulatory Science Consortium Meeting on Disease Progression Modeling for Duchenne Muscular Dystrophy (2017) (4)
- Skeletal Muscle in Spinal Muscular Atrophy As an Opportunity for Therapeutic Intervention (2017) (4)
- A proteasome inhibitor fails to attenuate dystrophic pathology in mdx mice. (2012) (3)
- P NMR Spectroscopy , Chemical Analysis , and Free Mg 2 + of Rabbit Bladder and Uterine Smooth Muscle (2001) (3)
- Use of the Six-Minute Walk Distance (6MWD) Across Duchenne Muscular Dystrophy (DMD) Studies (P3.121) (2016) (3)
- Status of therapeutic gene transfer to treat cardiovascular disease in dogs and cats. (2011) (3)
- Metabolic and contractile protein expression in single muscle fibers of the snake (1988) (2)
- A randomized, placebo-controlled, double-blind, Phase 1b/2 study of the novel antimyostatin adnectin RG6206 (BMS-986089) in ambulatory boys with Duchenne muscular dystrophy (P5.431) (2018) (2)
- O15 Emerging results from the Imaging DMD study (2014) (2)
- G.P.101 CAT-1004, a novel anti-Inflammatory agent under development for treatment of Duchenne muscular dystrophy (2014) (2)
- Leg muscle MRI in identical twin boys with duchenne muscular dystrophy (2018) (2)
- DIFFERENTIAL MYOSIN ISOZYME DISTRIBUTIONS AND SHORTENING VELOCITIES OF RABBIT SKINED SKELETAL MUSCLE FIBERS (1985) (2)
- Too much of a good thing (2018) (2)
- DISTINCT FAMILIES OF Z-LINE TARGETING MODULES IN THE C-TERMINAL REGION OF NEBULIN(Cell Biology and Morphology)Proceedings of the Seventy-First Annual Meeting of the Zoological Society of Japan : (2000) (1)
- Correction (2020) (1)
- Expression and functional assessment of hypertrophic cardiomyopathy-linked missense mutants of cardiac troponin T. (1997) (1)
- Changes in inorganic phosphate and force production in human skeletal muscle following cast immobilization (2004) (1)
- MoveDMD®: Positive Effects of Edasalonexent, an NF-κB Inhibitor, in 4 to 7-Year Old Patients with Duchenne Muscular Dystrophy in Phase 2 Study with an Open-Label Extension (S29.006) (2018) (1)
- Evaluation of the DBA/2J mouse as a potential background strain for genetic models of cardiomyopathy (2022) (1)
- Simultaneous tracking of two motor domains reveals near simultaneous steps and stutter steps of myosin 10 on actin filament bundles. (2020) (1)
- T.P.4.01 Identification and characterization of small molecules for the treatment of Duchenne muscular dystrophy (2007) (1)
- DMD CLINICAL THERAPIES I P.123A randomized, placebo-controlled, double-blind, phase 1b/2 study of the novel anti-myostatin adnectin RG6206 (BMS-986089) in ambulatory boys with Duchenne muscular dystrophy (2018) (1)
- Meeting Report: New Directions in the Biology and Disease of Skeletal Muscle 2014. (2014) (1)
- Themotormechanism ofmyosin V: insights formuscle contraction (2005) (1)
- Exon-skipped dystrophins for treatment of Duchenne Muscular Dystrophy : domain structures based on single molecule mechanics with cooperativity in forced unfolding as a key to design (2011) (1)
- Functional muscle hypertrophy by increased insulin‐like growth factor 1 does not require dysferlin (2019) (1)
- Abstract 9504: Phosphodiesterase Modulation of Cardiomyopathy in Murine and Canine Models of Muscular Dystrophy Treated With Sildenafil and Tadalafil (2012) (1)
- G.P.253: CAT-1004, an oral agent targeting NF-κB in development for treatment of Duchenne muscular dystrophy: Phase 1/2 study design (2015) (1)
- Treatment of experimental heart failure with hepatocyte growth factor (2003) (1)
- Combinated transfection of wild type and a hypertrophic cardiomyopathy mutant cardiac troponin T makes quail myotubes likely good turn in expression and functional assessment. (1996) (1)
- O.42Treatment of young boys with Duchenne muscular dystrophy with the NF-κB inhibitor edasalonexent showed a slowing of disease progression as assessed by MRI and functional measures (2019) (1)
- MYOSTATIN INHIBITION AFTER EXPERIMENTAL HEART FAILURE IMPROVES CARDIAC FUNCTION AND MUSCLE WASTING (2014) (1)
- Meeting Report: New Directions in Biology and Disease of Skeletal Muscle 2014. (2014) (1)
- G.P.227 Genetic polymorphisms modify intramuscular fat infiltration in Duchenne muscular dystrophy (2015) (1)
- GMCSF and SDF treatment induces neovasculogenesis in a mouse ischemic hindlimb model (2004) (1)
- TNF inhibition at the time of myocardial infarction attenuates the subsequent development of heart failure (2004) (1)
- Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA (2017) (1)
- Analysis of Telomere Length in the Aged mdx Diaphragm with and without Transgenic IGF-I Expression (2003) (1)
- Crystal structure of myosin X motor domain with 2IQ motifs in pre-powerstroke state (2016) (0)
- Delineating the design features underlying the stepping mechanism of class X myosin (2022) (0)
- LIGASE CHAIN REACTION FOR DIAGNOSIS OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (1998) (0)
- Functional implications of order-disorder transitions of myosin heads on thick filaments (1999) (0)
- chains in single muscle fibers Quantitative electrophoretic analysis of myosin heavy (2015) (0)
- How Do Myosin VI and Myosin Va Navigate Intersections And Cooperate On Actin Tracks While Transporting Cargo In Vitro (2009) (0)
- EM.P.1.07 Effects of muscle hypertrophy on individual myonuclear domain sizes in single muscle fibers from myostatin deficient or IGF-1 over-expressing mice (2009) (0)
- Myosin VI motor domain in the PPS state - from a Pi release state crystal, space group P212121 after long soaking with PO4 (2015) (0)
- Minisymposium 3: Tug of War: Molecular Motor Interactions (0)
- impedance of cultured airway smooth muscle cells Effect of the cytoskeletal prestress on the mechanical (2015) (0)
- MYOSTATIN INHIBITION IMPROVES CARDIAC GLUCOSE METABOLISM IN A MURINE MODEL OF OBESITY (2015) (0)
- Dimerization is Essential for the Large Step Size of Myosin VI (2010) (0)
- Crystal Structure Of Myosin V Motor With Essential Light Chain + ADP-BeFx - Near Rigor (2005) (0)
- Corrigendum to Sarcomeric-alpha-actinin defective in vinculin-binding causes Z-line expansion and nemaline-like body formation in cultured chick myotubes [Experimental Cell Research 315 (2009) 748―759] (2009) (0)
- Myosin VI motor domain in the Pi release state, space group P212121 - soaked with PO4 - located in the active site (2015) (0)
- 932-85 Altered Muscle Fiber Sarcomeres in Hypertrophic Cardiomyopathy Associated with the 403Arg-→Glnβ-Myosin Heavy Chain Gene Mutation (1995) (0)
- Myosin VI motor domain A458E mutant in the Pi release state, space group P212121 - (2015) (0)
- A Suitably Compliant Microenvironment Commits Mesenchymal Stem Cells to Differentiate into Muscle Like Cells Which Restore Muscular Defects in Dystrophic Models (2010) (0)
- Myosin Va and Myosin VI Engage in a “Tug of War” on Actin Tracks while Transporting Cargoes in vitro (2010) (0)
- Crystal structure of myosin X motor domain in pre-powerstroke state (2016) (0)
- unloading plus resistance exercise expression in human skeletal muscle: effect of limb Pretranslational markers of contractile protein (2015) (0)
- EXPRESSION AND FUNCTIONAL ASSESSMENT OF WILD-TYPE AND A HYPERTROPHIC CARDIOMYOPATHY MUTANT CARDIAC TROPONIN-T IN QUAIL MYOTUBES (1995) (0)
- Activities Supported by PPMD Laboratory of (2008) (0)
- The Force Producing ADP State of Myosin Bound to Actin (2016) (0)
- Homework I - Mechanical stiffness (2008) (0)
- Myosin II Dictyostelium discoideum motor domain S456E bound with MgADP-AlF4 (2006) (0)
- Abstract 13291: Left Ventricular Assist Device Support is Associated with Sustained Cardiac CamKII Activation and Increased MEF2 (2014) (0)
- Analyses of recombinant mutant cardiac troponin T in vitro and in myocyte culture (1997) (0)
- hypertrophyaccumulation during skeletal muscle The relationships among IGF-1, DNA content, and (2015) (0)
- Abstract 18709: Myostatin Expression is Markedly Increased after Biventricular Mechanical Support in Congenital Heart Disease (2010) (0)
- Myosin VI (MD-insert2-CaM, Delta Insert1) Post-rigor state (crystal form 2) (2007) (0)
- Myosin VI (MD) pre-powerstroke state (Mg.ADP.VO4) (2007) (0)
- Processive Cargo Movement by Multiple Non-Processive Motors Bound to a Tetrameric Adapter Protein (2011) (0)
- Nanostripes Developed on Batio3 Surface by Nc-afm, Dongbo Li and Dawn Bonnell (2007) (0)
- Abstract 67: A Rare Variant in Myh11, R247C, Affects Smooth Muscle Cell Phenotype and Acts as a Modifier for Aortic Disease (2012) (0)
- Crystal Structure Of Myosin V Motor Domain - Nucleotide-Free (2005) (0)
- Myosin VI motor domain in the Pi release state, space group P212121 (2015) (0)
- An insightful myosin structure reveals how actin triggers force production (2014) (0)
- Dicty myosin II R238E.E459R mutant (with ADP.Pi) in the Pi release state (2015) (0)
- Structural description of the ATPase cycle of a myosin that moves backward (2008) (0)
- Activin IIB receptor blockade improves muscular function in a mouse model of spinal muscular atrophy (2012) (0)
- 680 INTERACTIONS BETWEEN FREQUENCY, LENGTH, AND TENSION IN MOTOR UNITS OF VARYING SPEEDS A. G. Nelson (1990) (0)
- Abstract 2520: Blocking muscle wasting via deletion of the muscle specific E3 ligase, MuRF1, impedes pancreatic tumor growth (2023) (0)
- Declines in peak oxygen consumption due to both aging and chronic ethanol consumption (1986) (0)
- Myosin VI Dimerizes And Walks Processively Along Actin (2009) (0)
- Myosin lever arm (2009) (0)
- Abstract 16584: Bone Morphogenetic Protein 1/Tolloid-Like Metalloproteinase (BMP-1/TLD) is Increased in Heart Failure and Regulates MMP12 and TIMP1 Levels in Cardiomyocytes (2016) (0)
- Differential requirement for individual sarcoglycans in the function of the dystrophin-glycoprotein complex (2000) (0)
- Abstract 404: Catheter Based Delivery of scAAV6 Leads to High Level, Global Gene Transfer to the Canine Heart Superior to scAAV8, scAAV9, and ssAAV9 (2007) (0)
- Special topic: molecular motors of eukaryotic cells. Introduction. (1996) (0)
- 2P166 Direct observation of functioning myosin VI by high-speed AFM(11. Molecular motor,Poster,The 52nd Annual Meeting of the Biophysical Society of Japan(BSJ2014)) (2014) (0)
- Insulin-like Growth Factor-1 Gene Transfer Augments Muscle IGF Protein Content Despite Cast Immobilization: 799 (2006) (0)
- Actin-myosin Kinetic Cycle and phosphate release (2016) (0)
- Adhesion of myocytes: cytoskeletal contributions assessed by peeling from micropatterned collagen (1999) (0)
- Abstract 2881: Cardiac Gene Transfer of shRNA Directed Against Phospholamban Effectively Knocks Down Gene Expression But Causes Myocarditis and Death in Canines (2008) (0)
- DMD – THERAPY P.282 Edasalonexent treatment in young boys with Duchenne muscular dystrophy is associated with age-normative growth and normal adrenal function (2020) (0)
- Crystal Structure Of Myosin V Motor Without nucleotide soaked in 10 mM MgADP (2005) (0)
- Abstract 959: Myostatin Regulation in Patients with Advanced Heart Failure and After Mechanical Unloading (2006) (0)
- P3.20 Mouse and human skeletal muscle cells differentiate in a temperature-dependent manner (2010) (0)
- Impact of Viral Mediated Overexpression of IGF-I on Skeletal Muscle (2009) (0)
- G.P.3.06 Identification and characterization of small molecules for the treatment of Duchenne muscular dystrophy (2007) (0)
- Bowman-Birk inhibitorsammensætninger for the treatment of muscle atrophy and degenerative muscle disease (2004) (0)
- P.92 Magnetic resonance biomarkers in the proximal and distal upper extremity in a large cohort of boys with Duchenne muscular dystrophy (2017) (0)
- DMD CLINICAL THERAPIES I P.116Edasalonexent, an NF-κB Inhibitor, slows disease progression over more than a year compared to control period in 4 to 7 year old patients with Duchenne muscular dystrophy (2018) (0)
- PROCEEDINGS of the XVI CONGRESS OF THE ITALIAN SOCIETY OF MYOLOGY Lecce, Italy June 8-11, 2016 (2016) (0)
- P.69 Minimum clinically important difference in magnetic resonance biomarkers in DMD (2022) (0)
- Move DMD Results: Effects of Edasalonexent, an NF-kB Inhibitor, in 4 to 7 Year Old Patients with Duchenne Muscular Dystrophy (P3.210) (2017) (0)
- Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging (2022) (0)
- Postnatal PGC‐1α over‐expression improves muscle function in a mouse model of Duchenne muscular dystrophy (2009) (0)
- Towards regulatory endorsement of drug development tools to promote the application of model-informed drug development in Duchenne muscular dystrophy (2019) (0)
- P.230 CAT-1004, an oral agent targeting NF-kB: MoveDMD trial results in Duchenne muscular dystrophy (DMD) (2016) (0)
- Blocking muscle wasting via deletion of the muscle specific E3 ubiquitin ligase MuRF1 impedes pancreatic tumor growth (2023) (0)
- DMD CLINICAL THERAPIES I P.117Edasalonexent, an oral NF-κB inhibitor, in development for treatment of Duchenne muscular dystrophy: the phase 3 POLARIS study design (2018) (0)
- Abstract 34: Myh11 R247C is a Modifier Allele for Aortic Disease (2013) (0)
- Evaluating Genetic Modifiers of Duchenne Muscular Dystrophy Disease Progression Using Modeling and MRI (2022) (0)
- P1.41 Design of a multi-center study to examine skeletal muscles of children with Duchenne muscular dystrophy using MRI/MRS (2011) (0)
- Modulation of Striated Muscle Function is Reflected by Thick Filament Structure. (2000) (0)
- P.397 MoveDMD: phase 2 trial of edasalonexent, an NF-κB inhibitor, in 4 to 7-year old patients with Duchenne muscular dystrophy (2017) (0)
- T.I.12 MRI as a biomarker for DMD disease progression and implications for clinical trials (2016) (0)
- Reply to Sun et al.: Myosin VI movement: Wiggly or straight? (2010) (0)
- DUCHENNE MUSCULAR DYSTROPHY – IMAGING AND BIOMARKERS P.34MR biomarkers in imaging DMD clinical trial network (2018) (0)
- DUCHENNE MUSCULAR DYSTROPHY - PHYSIOTHERAPY P.305Disease progression in arm versus leg muscles in Duchenne muscular dystrophy (2018) (0)
- Single-Molecule and Molecular Dynamics Study of the Dimerization of Myosin VI Medial Tail Domain (2010) (0)
- Molecular Motors of Eukaryotic Cells (1996) (0)
- [Pathophysiological Study on Thoracic Ascending Aorta of Mice with Myh11 R247C Heterozygous Mutation in Norepinephrine-induced Hypertension Model]. (2020) (0)
- Abstract 14703: Angiotensin Receptor Blockade Positively Regulates MMP2 and TIMP1 in Patients With Aortic Aneurysms (2013) (0)
- 813 INCREASING OXIDATIVE CAPACITY OF SKELETAL MUSCLE DOES NOT NECESSITATE AN INCREASE IN VO2 MAX (1990) (0)
- Dictyostelium discoideum Myosin II motor domain S456E with bound MgADP-BeFx (2006) (0)
- Myosin VI nucleotide-free (MDINSERT2) D179Y crystal structure (2005) (0)
- ratsg fast muscles of hypophysectomized Growth hormone, IGF-I, and exercise effects on (2015) (0)
- Steered Molecular Dynamics Simulation of Unfolding of Myosin VI Proximal Tail Domain (2010) (0)
- MYOSIN VI D179Y (MD-INSERT2-CAM, DELTA-INSERT1) post-rigor state (2007) (0)
- Myosin VI motor domain in the Pi release state (with Pi) space group P21 (2015) (0)
- Potential limitations of micro-dystrophin gene therapy for Duchenne muscular dystrophy (2022) (0)
- The Medial-tail Domain of Myosin-VI as a Dimerization Region (2009) (0)
- MYOSTATIN INHIBITION IMPROVES CARDIAC GLUCOSE METABOLISM IN A MURINE MODEL OF HEART FAILURE (2015) (0)
- PNAS Plus Significance Statements (2016) (0)
- 05 Viral gene transfer of ARC and BCL-2 confers similar protection against cardiomyopathy after myocardial ischemia (2002) (0)
- Crystal structure of Myosin V motor with essential light chain-nucleotide-free (2003) (0)
- Treatment with granulocyte monocyte colony stimulating factor and stromal cell derived factor-1alpha enhances endothelial progenitor cell mediated myocardial perfusion and viability in ischemic cardiomyopathy (2005) (0)
- MYOSIN VI (MDinsert2-GFP fusion) PRE-POWERSTROKE STATE (MG.ADP.AlF4) (2012) (0)
- Chemical shift-based imaging to measure fat fractions in dystrophic skeletal muscle (2012) (0)
- Cargo-mediated dimerization of Myosin VI (2009) (0)
- Suppression of Premature Stop Codons for the Treatment of a Subset of Patients with Genetic Disorders (2009) (0)
- Myosin VI motor domain in the Pi release state, space group P212121 - shortly soaked with PO4 (2015) (0)
- markers of protein deficits Atrophy responses to muscle inactivity. II. Molecular (2015) (0)
- MYOSIN VI (MD-INSERT2-CAM, DELTA-INSERT1) post-rigor state - long soaking with PO4 (2015) (0)
- Tracking of Labeled Motor Domains of Single Full-Length Myosin X on Actin Bundles (2019) (0)
- Myosin VI (MD) pre-powerstroke state, P21 crystal form (2012) (0)
- CELLS ON GELS : ADHESION VERSUS DIFFERENTIATION OF SKELETAL MUSCLE CELLS (0)
- Cardiac gene transfer of HGF is superior to TMR in inducing therapeutic coronary neoangiogenesis (2000) (0)
- Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 359 (1452) (2004) (0)
- Myosin VI D179Y (MD) pre-powerstroke state (2013) (0)
- Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences: 359 (1452) (2004) (0)
- Myosin VI D23R I24R R569E (MD) pre-powerstroke state (2012) (0)
- AAV 6-mediated delivery of a U 7 exon skipping construct improves regional cardiac function in Golden Retriever muscular dystrophy dogs (2010) (0)
- DIFFERING PATTERNS OF MYOSTATIN SIGNALING REGULATE HYPERTROPHY IN SEVERE AORTIC STENOSIS AND HYPERTROPHIC CARDIOMYOPATHY (2014) (0)
- Kenneth C. Holmes (1934-1921). (2022) (0)
- Adeno-Assocated Virus ( AAV ) Serotype 9 Provides Global Cardiac Gene Transfer Superior to AAV 1 , AAV 6 , AAV 7 , and AAV 8 in the Mouse and Rat (2018) (0)
- Myosin Vc pre-powerstroke state (2016) (0)
- Insulin-like Growth Factor-1 Gene Transfer Augments Muscle Protein Synthesis Rate And Size In Adult Mice: 406 Board #6 (2005) (0)
- Lever Arm Length Determines The Azimuthal But Not The Axial Orientation Of Myosin V During Processive Motility (2009) (0)
- The Six-Minute Walk Test (6MWT) as Endpoint in Duchenne Muscular Dystrophy (DMD) Clinical Studies (2016) (0)
- INCREASED MYOSTATIN IS ASSOCIATED WITH DECREASED AMPK AND WORSENED CARDIAC FUNCTION IN HEART FAILURE WITH PREVIOUS INSULIN RESISTANCE (2016) (0)
This paper list is powered by the following services:
Other Resources About Lee Sweeney
What Schools Are Affiliated With Lee Sweeney?
Lee Sweeney is affiliated with the following schools:
- University of Alabama
- University of Oxford
- University of Florida
- University of Chicago
- Stanford University
- Massachusetts Institute of Technology
- University of Texas Health Science Center at Houston
- Massachusetts General Hospital
- University of Florida College of Medicine
- University of Pennsylvania
- Harvard University
